fda warning letters bpc-157 peptide not approved BPC 157 Banned: Key Facts on the Latest Decision FDA considers widening access to

BPC-157 Research Peptide BPC-157 (Body Protection Compound 157) is a synthetic pentadecapeptide (15 amino acids) derived from a protective protein in human gastric juice, first isolated by Dr

This therapy should not be used during pregnancy or while breastfeeding

Active cancer or history of malignancy Pregnancy or breastfeeding Known peptide allergies Athletes subject to anti-doping testing (WADA prohibited) Raynauds disease or phenomenon Cold urticaria (hives from cold) Uncontrolled hypertension Peripheral vascular disease Open wounds (for local application) Pregnancy Cardiovascular conditions Diabetes (especially with neuropathy) Current infections Immunosuppression Blood clotting disorders Quality control issues represent perhaps the greatest practical risk with BPC-157

research-stage peptides show even more dramatic individual differences